1266 related articles for article (PubMed ID: 28400218)
1. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
3. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
[TBL] [Abstract][Full Text] [Related]
6. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
8. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
9. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
10. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease.
Maitrias P; Deltombe G; Molin V; Reix T
J Vasc Surg; 2017 Feb; 65(2):406-413. PubMed ID: 27693029
[TBL] [Abstract][Full Text] [Related]
11. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
12. Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Wauters J
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):617-625. PubMed ID: 33231029
[TBL] [Abstract][Full Text] [Related]
13. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
16. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
[TBL] [Abstract][Full Text] [Related]
17. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
18. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
[TBL] [Abstract][Full Text] [Related]
19. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
[TBL] [Abstract][Full Text] [Related]
20. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
Jebran AF; Popov AF; Zenker D; Bireta C; Friedrich M; Danner BC; Bougioukas I; Schoendube FA; Stojanovic T
Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
